English Français

Medexus Pharmaceuticals, Inc. Medexus Pharmaceuticals, Inc.

  • English
  • About
    • Overview
    • Growth Strategy
    • Management Team
    • Board of Directors
  • Our Portfolio
    • Overview
    • Canadian Product Portfolio
    • US Product Portfolio
  • News
    • Press Releases
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Presentation
    • Financial Results
    • Stock Data
    • Governance
    • SEDAR+
  • Contact
  • Careers
  • English
  • Français

Press Releases

News

News

  • Press Releases
  • Events
Sep 28, 2023 7:34pm EDT

Medexus and medac Agree to Amend US Treosulfan Agreement

Sep 21, 2023 5:00pm EDT

Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors

Sep 05, 2023 6:41pm EDT

Medexus Pharmaceuticals Announces C$10 Million Bought-Deal Public Offering of Units

Sep 05, 2023 7:30am EDT

Medexus Strengthens Balance Sheet with US$18 Million Commitment Under Accordion Facility

Aug 17, 2023 5:30pm EDT

Medexus Study Supports Efficacy and Safety of IXINITY in Pediatric Patients with Severe or Moderately Severe Hemophilia B

Aug 09, 2023 5:30pm EDT

Medexus Announces Strong Fiscal Q1 2024 Results, Including Record Quarterly Revenue of US$31.6 Million

Aug 04, 2023 7:00am EDT

Medexus to Participate in Fireside Chat at SHARE Series Event

Aug 02, 2023 7:00am EDT

Medexus Schedules First Fiscal Quarter 2024 Conference Call

Jul 12, 2023 5:30pm EDT

Medexus Announces Preliminary Revenue for Fiscal Q1 2024

Jun 21, 2023 5:40pm EDT

Medexus Generates Record Revenue of Us$108.1 Million in Fiscal Year 2023

RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...15
Next
© 2023 Medexus Pharmaceuticals, Inc.
All Rights Reserved.
Facebook Facebook
Privacy Policy Disclaimer Sitemap

Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.